Pub. Date : 2021 Oct
PMID : 34129075
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The ODC inhibitor alpha-difluoromethylornithine (DFMO, or Eflornithine) has been FDA-approved for the treatment of trypanosomiasis and hirsutism and has advanced to clinical cancer trials including NB as well as cancer-unrelated human diseases. | Eflornithine | ornithine decarboxylase 1 | Homo sapiens |
| 2 | The ODC inhibitor alpha-difluoromethylornithine (DFMO, or Eflornithine) has been FDA-approved for the treatment of trypanosomiasis and hirsutism and has advanced to clinical cancer trials including NB as well as cancer-unrelated human diseases. | Eflornithine | ornithine decarboxylase 1 | Homo sapiens |
| 3 | The ODC inhibitor alpha-difluoromethylornithine (DFMO, or Eflornithine) has been FDA-approved for the treatment of trypanosomiasis and hirsutism and has advanced to clinical cancer trials including NB as well as cancer-unrelated human diseases. | Eflornithine | ornithine decarboxylase 1 | Homo sapiens |